Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT03055702
  4. Details
NCT03055702 Clinical Trial

Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients

Diabetes Mellitus, Type 2 Clinical Trial

Official title:
Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03055702
Other study ID # KW/EX-16-104(100-10)
Secondary ID
Status Recruiting
Phase N/A
First received February 14, 2017
Last updated February 14, 2017
Start date November 1, 2016
Est. completion date March 30, 2018

Study information
Verified date February 2017
Source The University of Hong Kong
Contact Man Chi Dao, M.B.B.S.
Phone +85236515411
Email thomasmcdao@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.

Description:

The main objective of this study is to evaluate the appointment attendance rate using SMS reminder of nurses and allied health appointments for diabetic patients, when compared to conventional telephone reminder and no reminder. We also aim at determine the factors associated with appointment attendance. Finally, we will also survey patients' acceptance and satisfaction to the SMS service.

This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic.

The primary outcome of this study is to evaluate the attendance rate of each individual doctor, nurses and allied health clinic appointments for diabetic patients, as well as their overall attendance rates:

1. Diabetes Complication Screening Clinic (OPAS DMCS/RDNA)

2. Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI)

3. DM nurse group (OPAS RDNG)

4. Dietitian Counselling (OPAS DC/DG)

5. Physiotherapy (OPAS PTC/PTG)

6. Diabetes Doctor Session (OPAS RDR)

7. Retino photo Assessment (OPAS RDO)

8. Blood taking appointment (OPAS LABT)

The secondary outcomes are:

- Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder

- Factors associated with acceptance of SMS

1. Personal Parameters: Age, sex, educational level, occupation, mobile phone models, Habit of using mobile phone service

2. Disease Parameters: Number and types of comorbidity, disease control (by biochemical markers)

3. Quality of Life (by SF-6D)

- Reported adverse effects of the reminder system

- Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later

Subjects who agreed to participate in this study will first receive a survey on the acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized to:

1. an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or

2. usual care with no reminder / telephone reminder.

Recruitment information / eligibility
Status Recruiting
Enrollment 270
Est. completion date March 30, 2018
Est. primary completion date June 30, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- With diagnosis of type 2 diabetes

- Have more than 1 clinic services appointment under RAMP-DM programme:

(e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)

Exclusion Criteria:

1. Cannot read or receive appointment schedule on mobile phone

2. Do not speak Cantonese/English or read Chinese/English

3. Mentally incapacitated

4. Pregnant Women

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Mobile phone text message reminder
an SMS remind subjects to come for scheduled clinic appointment 24-72 hours before

Locations
Country Name City State
Hong Kong Ha Kwai Chung General Outpatient Clinic Kwai Chung

Sponsors (2)
Lead Sponsor Collaborator
The University of Hong Kong Hospital Authority, Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome
Type Measure Description Time frame Safety issue
Primary Attendance Rate of the scheduled clinic appointment Attendance Rate between booking time and appointment time, usually within 1 weeks to 16 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2